CN1399917A - Cancer-resisting sausage - Google Patents
Cancer-resisting sausage Download PDFInfo
- Publication number
- CN1399917A CN1399917A CN01124511A CN01124511A CN1399917A CN 1399917 A CN1399917 A CN 1399917A CN 01124511 A CN01124511 A CN 01124511A CN 01124511 A CN01124511 A CN 01124511A CN 1399917 A CN1399917 A CN 1399917A
- Authority
- CN
- China
- Prior art keywords
- sausage
- cancer
- resisting
- vitamin
- sodium nitride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Meat, Egg Or Seafood Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Conventionally the sodium nitride is used as preservative for sausage meat, and in the interior of human body the sodium nitride can be formed into amine nitrite which is a carcinogenic substance. Said invented "cancer-preventing sausage" can prevent the formation of amine nitrite. It is characterized by that in the production of sausage the proper quantity of vitamin C is added.
Description
Pork in the sausage is normally made anticorrisive agent with natrium nitrosum.This anticorrisive agent combines with amine in the meat proteins in stomach, forms nitrosamine, and this is a kind of carcinogenic substance.And vitamin C can hinder nitrite and combines with amine, thereby suppresses the formation of nitrosamine.
The present invention's " cancer-resisting sausage " is when the system sausage, adds appropriate vitamin C in sausage.
Because vitamin C can hinder nitrite and combines with amine, vitamin C can stop anticorrisive agent natrium nitrosum in the sausage to combine with amine in the meat proteins in stomach, thus the formation of resistance nitrosamine.
Claims (1)
1. sausage, it is characterized in that: the batching of this sausage has vitamin C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01124511A CN1399917A (en) | 2001-07-27 | 2001-07-27 | Cancer-resisting sausage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01124511A CN1399917A (en) | 2001-07-27 | 2001-07-27 | Cancer-resisting sausage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1399917A true CN1399917A (en) | 2003-03-05 |
Family
ID=4665713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01124511A Pending CN1399917A (en) | 2001-07-27 | 2001-07-27 | Cancer-resisting sausage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1399917A (en) |
-
2001
- 2001-07-27 CN CN01124511A patent/CN1399917A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002096363A3 (en) | Method for treating fibrotic diseases or other indications | |
MX2007003013A (en) | Bicyclic amides as kinase inhibitors. | |
WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
ZA200004569B (en) | Infusion of liquids into the human or animal body. | |
WO2009034315A3 (en) | Vaccine | |
CU23260B7 (en) | MOXIFLOXACINE PHARMACEUTICAL PREPARATION | |
CA2396865A1 (en) | Farnesyl protein transferase inhibitors for treating breast cancer | |
WO2006071952A3 (en) | Compositions and methods for improving kidney function | |
EP1614675A3 (en) | Amino acids with affinity for the alpha-2-delta protein | |
WO2007118963A3 (en) | Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof | |
PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
WO2003048205A3 (en) | Novel proteins with il-6 inhibiting activity | |
WO2004091591A3 (en) | Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof | |
WO2002062304A3 (en) | Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate | |
WO2002096348A3 (en) | Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment | |
WO2004039326A3 (en) | Propofol with cysteine | |
MX2007003633A (en) | Activated globular protein and its use in edible compositions. | |
BR0313031A (en) | Spicy particle, food product, process for the preparation of a particle and use of a spicy particle | |
CN1399917A (en) | Cancer-resisting sausage | |
MXPA02012857A (en) | Use of a formulation made of or containing at least one dissimilated milk serum. | |
MXPA04002594A (en) | Composition comprising cysteamine for improving lactation in dairy animals. | |
WO2004006830A3 (en) | Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux | |
WO2002054881A3 (en) | The use of food and drink as a delevery system for phytase in humans | |
PT1460084E (en) | Novel peptide sy | |
WO2001068676A3 (en) | Lhrh-antagonists, production and use thereof as medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |